Cloud-Based Drug Discovery Platforms: Global Strategic Business Report

Quick Summary:

In an ever-changing environment of healthcare technology, understanding the dynamics of the Cloud-Based Drug Discovery Platforms Market is crucial for stakeholders aiming to stay ahead of the curve in their strategic planning. Our exhaustive research report delivers an unparalleled insight into a sector that is projected to expand from $3.7 Billion in 2022 to a staggering $9.7 Billion by 2030.

This report does not just provide the full picture of the market as it stands. It also offers projections for the future, helps track the progress of key segments such as Pharmaceutical and Biotech vendors, and highlights exciting geographical hotspots for growth. Furthermore, with the inclusion of our competitive landscape analysis, decision makers garner an in-depth understanding of the major players operating within the market. Stay ahead of your competition and make informed business decisions with our comprehensive market research report on Cloud-Based Drug Discovery Platforms. Your success story starts here.

Global Cloud-Based Drug Discovery Platforms Market to Reach $9.7 Billion by 2030

The global market for Cloud-Based Drug Discovery Platforms estimated at US$3.7 Billion in the year 2022, is projected to reach a revised size of US$9.7 Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2022-2030. Pharmaceutical Vendors, one of the segments analyzed in the report, is projected to record 13% CAGR and reach US$4.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biotech Vendors segment is readjusted to a revised 13.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 12% CAGR

The Cloud-Based Drug Discovery Platforms market in the U.S. is estimated at US$1.1 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 12% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.2% and 10.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR.

Select Competitors (Total 41 Featured) -

Accenture PLC
Acelot, Inc.
Cloud Pharmaceuticals, Inc.
Dassault Systemes
IBM Corporation
SAS Institute, Inc.
Tata Consultancy Services Ltd.
WuXi AppTec

What's New?

Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and Research Platform
Complimentary updates for one year

Frequently Asked Questions about the Global Market for Cloud-Based Drug Discovery Platforms

What is the estimated value of the Global Market for Cloud-Based Drug Discovery Platforms?

The Global Market for Cloud-Based Drug Discovery Platforms was estimated to be valued at $3.7 Billion in 2022.

What is the growth rate of the Global Market for Cloud-Based Drug Discovery Platforms?

The growth rate of the Global Market for Cloud-Based Drug Discovery Platforms is 12.8%, with an estimated value of $9.7 Billion by 2030.

What is the forecasted size of the Global Market for Cloud-Based Drug Discovery Platforms?

The Global Market for Cloud-Based Drug Discovery Platforms is estimated to be worth $9.7 Billion by 2030.

Who are the key companies in the Global Market for Cloud-Based Drug Discovery Platforms?

Key companies in the Global Market for Cloud-Based Drug Discovery Platforms include Accenture PLC, Acelot, Inc., Cloud Pharmaceuticals, Inc., Dassault Systemes, IBM Corporation, SAS Institute, Inc., Tata Consultancy Services Ltd. and WuXi AppTec.

Report Attribute	Details
No. of Pages	194
Published	October 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 3.7 Billion
Forecasted Market Value ( USD ) by 2030	$ 9.7 Billion
Compound Annual Growth Rate	12.8%
Regions Covered	Global

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Cloud-Based Drug Discovery Platforms - Global Key Competitors Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 2: World 8-Year Perspective for Cloud-Based Drug Discovery Platforms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
Table 3: World Recent Past, Current & Future Analysis for Pharmaceutical Vendors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 4: World 8-Year Perspective for Pharmaceutical Vendors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
Table 5: World Recent Past, Current & Future Analysis for Biotech Vendors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 6: World 8-Year Perspective for Biotech Vendors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 8: World 8-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
Table 9: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 10: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
Table 11: World Cloud-Based Drug Discovery Platforms Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
Table 12: USA Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 13: USA 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

CANADA

Table 14: Canada Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 15: Canada 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

JAPAN

Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 16: Japan Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 17: Japan 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

CHINA

Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 18: China Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 19: China 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

EUROPE

Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 20: Europe Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 21: Europe 8-Year Perspective for Cloud-Based Drug Discovery Platforms by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
Table 22: Europe Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 23: Europe 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

FRANCE

Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 24: France Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 25: France 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

GERMANY

Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 26: Germany Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 27: Germany 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

ITALY

Table 28: Italy Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 29: Italy 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

UNITED KINGDOM

Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 30: UK Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 31: UK 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

REST OF EUROPE

Table 32: Rest of Europe Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 33: Rest of Europe 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

ASIA-PACIFIC

Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 34: Asia-Pacific Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 35: Asia-Pacific 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

REST OF WORLD

Table 36: Rest of World Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
Table 37: Rest of World 8-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical Vendors, Biotech Vendors, Contract Research Organizations and Other End-Uses for the Years 2023 & 2030

IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

Accenture PLC
Acelot, Inc.
Cloud Pharmaceuticals, Inc.
Dassault Systemes
IBM Corporation
SAS Institute, Inc.
Tata Consultancy Services Ltd.
WuXi AppTec

Quick Summary:

Global Cloud-Based Drug Discovery Platforms Market to Reach $9.7 Billion by 2030

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 12% CAGR

Select Competitors (Total 41 Featured) -

What's New?

What is the estimated value of the Global Market for Cloud-Based Drug Discovery Platforms?

What is the growth rate of the Global Market for Cloud-Based Drug Discovery Platforms?

What is the forecasted size of the Global Market for Cloud-Based Drug Discovery Platforms?

Who are the key companies in the Global Market for Cloud-Based Drug Discovery Platforms?

Table of Contents

Companies Mentioned

Related Topics

Related Reports

Cloud Services Global Market Report 2023

Drug Discovery Global Market Report 2023

Cloud-Based Drug Discovery Platform Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

Drug Discovery Informatics - Global Strategic Business Report

Biosimulation Technology: Global Strategic Business Report